Mark Simmons

6
Nov

Biofortuna in 2022

  2022 has been a remarkable year for our organisation. We have formed unique partnerships with some of the most innovative healthcare and life science companies that have saved time, mitigated risk and helped get products to market faster and more efficiently. Our partnerships are unique because they are based on the shared values of mutual respect, transparency and flexibility.

Read more

17
Aug

Re-defining the limits of single batch assay stabilisation

In response to increasing demand for stabilised molecular diagnostic assays, we have significantly increased our single batch lyophilised reagent bead manufacturing throughput to 300,000 reactions per freeze drying run and are now progressing towards a capacity of 100 million tests per annum. Utilising bespoke high precision automation, four dedicated freeze driers (each with 3.5m2 shelf capacity) housed in a 180m2

Read more

8
Jul

How lyophilised reagent beads increase assay accuracy

What are lyophilised reagent beads? Lyophilised reagent beads are durable spheres of freeze-dried material formed from accurately measured dispense volumes of customisable formulation. These single-dose beads – like lyophilised cakes – retain long-term stability at ambient temperature and therefore do not need expensive cold chain shipping or refrigeration during storage. This significantly increases the accessibility of diagnostic testing for difficult-to-reach

Read more

25
Mar

Welcome to the team Megan, Ish and Georgina

  Megan, Ish and Georgina are the latest cohort of Laboratory scientists to join us as we continue on our strategic growth journey that will see us become one of the world’s largest and most agile assay contract manufacturers. In November of last year,  we announced our relocation into a new, purpose built manufacturing facility and our intention to double

Read more

3
Feb

Biofortuna supports World Cancer Day

We are proud to support the UICC’s World Cancer Day initiative

1
Nov

Biofortuna relocates to purpose built facilities and more than doubles its capacity

Biofortuna (Deeside UK), a specialist contract development and manufacturing partner to the IVD and point of care testing sectors, has more than doubled its manufacturing capacity following its relocation to new state-of-the-art facilities in Deeside, North Wales.   The purpose-built facilities have been designed by the Company to provide the most efficient and modern manufacturing laboratories from which to meet

Read more

7
Sep

How are lyo beads manufactured?

Lyo beads are durable spheres of freeze-dried material formed from accurately measured and dispensed volumes of customisable formulation. These single-dose beads – like all lyophilised material – retain long-term stability at ambient temperature and therefore do not need expensive cold chain shipping or refrigeration during storage. This significantly increases the accessibility of diagnostic testing for difficult-to-reach patients, facilitating regular, near-patient

Read more

20
Jan

Biofortuna shortlisted for 2020 Bionow awards.

We are delighted to share the news that we have been shortlisted for the 2020 BioNow awards.

10
Dec

Biofortuna sets a new production record.

Biofortuna sees record production levels across November and December

Contact us